Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Skaug

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cytokine|January 28, 2019
Type I interferon dysregulation in Systemic SclerosisBrian Skaug, Shervin Assassi
Current Opinion in Rheumatology|August 23, 2019
Biomarkers in systemic sclerosisBrian Skaug, Shervin Assassi
Cell|October 16, 2010
Emerging role of ISG15 in antiviral immunityBrian Skaug, Zhijian J Chen
Idrugs : the Investigational Drugs Journal|April 8, 2010
SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International ConferenceBrian Skaug, Zhijian J Chen
Annual Review of Biochemistry|June 4, 2009
The role of ubiquitin in NF-kappaB regulatory pathwaysBrian Skaug, Xiaomo Jiang, Zhijian J Chen
BMJ Case Reports|April 13, 2016
Oesophageal rupture masquerading as STEMIBrian Skaug, Kenneth R Taylor, Somya Chandrasekaran
Molecular Cell|October 27, 2009
A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1betaMing Xu, Brian Skaug, Wenwen Zeng, et al.
The Journal of Biological Chemistry|April 1, 2006
Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family membersMeenakshi Upreti, Christopher S Lyle, Brian Skaug, et al.
Molecular Cell|November 22, 2011
Direct, noncatalytic mechanism of IKK inhibition by A20Brian Skaug, Jueqi Chen, Fenghe Du, et al.
Cell|July 26, 2011
MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune responseFajian Hou, Lijun Sun, Hui Zheng, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cytokine|January 28, 2019
Type I interferon dysregulation in Systemic SclerosisBrian Skaug, Shervin Assassi
Current Opinion in Rheumatology|August 23, 2019
Biomarkers in systemic sclerosisBrian Skaug, Shervin Assassi
Cell|October 16, 2010
Emerging role of ISG15 in antiviral immunityBrian Skaug, Zhijian J Chen
Idrugs : the Investigational Drugs Journal|April 8, 2010
SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International ConferenceBrian Skaug, Zhijian J Chen
Annual Review of Biochemistry|June 4, 2009
The role of ubiquitin in NF-kappaB regulatory pathwaysBrian Skaug, Xiaomo Jiang, Zhijian J Chen
BMJ Case Reports|April 13, 2016
Oesophageal rupture masquerading as STEMIBrian Skaug, Kenneth R Taylor, Somya Chandrasekaran
Molecular Cell|October 27, 2009
A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1betaMing Xu, Brian Skaug, Wenwen Zeng, et al.
The Journal of Biological Chemistry|April 1, 2006
Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family membersMeenakshi Upreti, Christopher S Lyle, Brian Skaug, et al.
Molecular Cell|November 22, 2011
Direct, noncatalytic mechanism of IKK inhibition by A20Brian Skaug, Jueqi Chen, Fenghe Du, et al.
Cell|July 26, 2011
MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune responseFajian Hou, Lijun Sun, Hui Zheng, et al.
Pageof 4